Using the GL261 model cell line, we showed in-vitro and in-vivo that blockade of TAMs using Pexidartinib/PLX3397, a blood brain barrier penetrant colony stimulating factor 1 receptor (CSF-1R) inhibitor, strongly suppresses TAM mediated glioma invasion [20]. This evidence concerns the gene CSF1R and central nervous system cancer.